7 Undervalued Health Care Equipment & Supplies Stocks for Monday, November 25
Discover the top 7 undervalued Health Care Equipment & Supplies stocks for Monday, November 25 based on AAII’s Stock Grades.Aneeqa Nadeem
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Commentary & Analysis
7 Undervalued Health Care Equipment & Supplies Stocks for Wednesday, October 23
Discover the top 7 undervalued Health Care Equipment & Supplies stocks for Wednesday, October 23 based on AAII’s Stock Grades.Jenna Brashear
3 Undervalued Advanced Medical Equipment & Technology Stocks for Thursday, August 01
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Thursday, August 01 based on AAII’s Stock Grades.Omar Beirat
3 Undervalued Advanced Medical Equipment & Technology Stocks for Friday, June 28
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Friday, June 28 based on AAII’s Stock Grades.
Eunice Kim
3 Undervalued Advanced Medical Equipment & Technology Stocks for Wednesday, May 01
Discover the top 3 undervalued Advanced Medical Equipment & Technology stocks for Wednesday, May 01 based on AAII’s Stock Grades.Jack Gilleland
Financial Summary
| Share Statistics | NUWE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4.1 | $407.7 | 3% |
|
| Shares Out (Mil) | 0.2 | 41.3 | 1% |
|
| Institutional Ownership | 99.5% | 81.4% | 89% |
|
| Float (Mil) | 3.0 | 34.9 | 8% |
|
| Beta | na | 0.88 | na |
|
| Avg Daily Volume (000s) | 485 | 412 | 57% |
|
| Price Change (52-week) |
(99.5%) | 64.8% | 1% |
|
| Growth | NUWE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.3% | 11.8% | 24% |
|
| Net Income (5yr) | (2.1%) | (6.0%) | 37% |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | NUWE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $9 | $119 | 8% |
|
| Net Income (TTM) (Mil) | ($11) | ($9) | 28% |
|
| EPS (TTM) | ($145.783) | ($0.400) | 0% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | ($3) | 18% |
|
| Net Cash Flow (TTM) (Mil) | $-0 | $1 | 41% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $21 | 0% |
|
| Enterprise Value (Q1) (Mil) | $0 | $427 | 4% |
|
| Valuation | NUWE | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.06 | na |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | NUWE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.7% | 58.9% | 81% |
|
| Net Margin | (125.6%) | (6.9%) | 7% |
|
| ROA | (123.6%) | (12.7%) | 4% |
|
| ROE | 205.6% | (13.1%) | 98% |
|
| Liabilities to Assets | 122.4% | 46.0% | 97% |
|
| F-Score | 3 | 4 | na |
|
Nuwellis, Inc. did not pass any screens on 8/20/2026.
